5 research outputs found
Testing Hepatitis A virus antibody in oral fluid among the prospective vaccinees foster the need of new oral HAV rapid test
No full textCombination of Three Rapid Tests: An Alternative Approach to Confirmatory Laboratory Diagnosis of HIV Infection in Bangladesh
No full textSeroprevalence of rubella among urban and rural Bangladeshi women emphasises the need for rubella vaccination of pre-pubertal girls
No full textHigh Prevalence of Hepatitis A virus Antibody among Bangladeshi Children and Young Adults Warrants Pre-immunization Acreening of Antibody in HAV Vaccination Strategy
No full textSerum samples from 465 subjects aged between 1 and 25 years were tested
for antibody against hepatitis A virus (HAV) [anti-HAV IgG and IgM] to
determine the seroprevalence of HAV antibody and do a cost-benefit
analysis for decision making about vaccination against HAV among the
general population of Bangladesh. A high prevalence of anti-HAV (74.8%)
was observed in the study population; the whole study population was
found positive for anti-HAV by the age of 25 years. On performing the
cost-benefit analysis, it was found that the cost for vaccination with
screening for anti-HAV was almost three times cheaper than vaccination
without screening. Thus, in the present socioeconomic condition of
Bangladesh, a policy based on screening for HAV antibody before
vaccination is recommended
